- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06522867
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
Reliability Evaluation of Intraocular Pressure At Day 1 Following Vitreoretinal Surgery, Comparing Goldmann Applanation Tonometry (Gold Standard) to Icare and Accupen
The goal of this prospective controlled study is to measure the reliability of two intraocular pressure (IOP)-measuring instruments in comparison to the gold standard, Goldmann applanation tonometry (GAT) following vitreo-retinal surgery. The main question the current study aims to answer is: are Icare and Accupen as accurate as GAT in measuring IOP one day post eye surgery?
Participants in this study will have their IOP measured by the three different instruments one day post-surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Goldmann applanation tonometry (GAT), used since 1948, is the reference technique for measuring intraocular pressure (IOP) in both healthy patients and those suffering from glaucoma or other eye disorders. However, the use of GAT requires the topical application of fluorescein, local anesthesia, and direct contact with the cornea. In addition to its lack of portability, these characteristics of GAT quickly led clinicians to try to find simpler, less cumbersome, but just as reliable techniques to measure IOP. Among the techniques developed to potentially replace GAT, two portable techniques are particularly easy to use: rebound tonometry (Icare) and portable applanation tonometry (Accupen). Before these techniques are universally and interchangeably used with GAT, their reliability and accuracy must be measured. The majority of studies have evaluated these techniques in glaucomatous or healthy eyes, presenting mixed but promising results. However, only one recent study has evaluated the validity of the two techniques (Icare and TonoPen) in a post-operative context of vitreo-retinal surgery. More data is therefore necessary to come to a definitive conclusion regarding the reliability of Icare and Accupen.
The objective of this study is therefore to determine whether the IOP measured by Accupen and/or Icare is as accurate as that taken by GAT in patients who have undergone vitreo-retinal surgery.
To answer this question, this project will be a prospective controlled study of 67 patients who have undergone vitreo-retinal surgery and who will have their intraocular pressure taken 1 day post-operatively by the 3 instruments mentioned above, in a randomized order. At their 1-day post-operative visit, an ocular medical history will be taken, including the preoperative diagnosis and the type of surgery performed. A resident in ophthalmology at Laval University, will take a series of 2 intraocular pressures with these 3 devices: GAT, Icare, and Accupen and will average for each group.
The project research hypothesis would be that the taking of intraocular pressure by Icare and/or Accupen is as valid as that taken by Goldman's applanation tonometry.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julie Mauger, BSc
- Phone Number: 84821 418-682-7511
- Email: cuo.recherche@fmed.ulaval.ca
Study Contact Backup
- Name: Sébastien Méthot, PhD
- Phone Number: 84821 418-682-7511
- Email: sebastien.methot@crchudequebec.ulaval.ca
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1S4L8
- Recruiting
- Hôpital du Saint-Sacrement, CHU de Québec - Université Laval
-
Contact:
- Mathieu Caissie, MD
-
Contact:
- Imad E Hachem, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18
- Received a vitreoretinal surgery
Exclusion Criteria:
- Corneal dystrophy
- Corneal surgery (penetrating keratoplasty, DSAEK/DMEK less than 6 months, radial keratotomy)
- Irregular corneal surface
- Active corneal ulcer
- Active epithelial deficit
- Central corneal scarring
- A history of scleral buckle
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intraocular pressure measure
|
The intraocular pressure of the subjects using either the Goldmann applanation tonometer, Icare or Accupen.
The order of the measure is randomized.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Absence of difference between intracular pressure measured by devices
Time Frame: at the post-operative visit (1 day after surgery)
|
No difference in the intraocular pressure measured by Accupen or Icare compared to Goldmann tonometer.
|
at the post-operative visit (1 day after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reliability and validity of devices at all intracular pressure level
Time Frame: at the post-operative visit (1 day after surgery)
|
The devices have the same intraocular pressure measured by Goldmann tonometer at High level of pressure (>24mmHg), moderate level (10-24mmHg) and low level (<10mmHg).
|
at the post-operative visit (1 day after surgery)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mathieu Caissie, MD, CHU de Quebec - Universite Laval
- Principal Investigator: Imad E Hachem, MD, CHU de Quebec - Universite Laval
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2024-7144
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
Icare Finland OyCompleted
-
Vanderbilt University Medical CenterEnrolling by invitation
-
Nidek Co. LTD.CompletedIntraocular PressureUnited Kingdom
-
Inonu UniversityCompletedIntraocular PressureTurkey
-
Medical University of ViennaCompletedIntraocular PressureAustria
-
Bausch & Lomb IncorporatedCompletedIntraocular PressureUnited States
-
Inonu UniversityCompletedIntraocular Pressure
-
The University of Texas Health Science Center,...Robert Cizik Eye ClinicCompletedIntraocular PressureUnited States
-
Isfahan University of Medical SciencesCompletedIntraocular PressureIran, Islamic Republic of
-
Tel-Aviv Sourasky Medical CenterUnknownIntraocular PressureIsrael
Clinical Trials on Intraocular pressure measure
-
Saglik Bilimleri UniversitesiCompletedIntraocular Pressure | Groin HerniaTurkey (Türkiye)
-
Hospital Civil de GuadalajaraUnknownIntraocular Pressure | Intracranial Pressure Increase | Children, Only | Trauma, BrainMexico
-
Benha UniversityRecruitingGlaucoma | Intraocular Pressure | Glaucoma, SuspectEgypt
-
Boston SightCompletedIntraocular Pressure and PROSE LensUnited States
-
Selcuk UniversityCompletedAbdominal Compartment SyndromeTurkey
-
Rabin Medical CenterRecruitingALL, Childhood | Steroid-Induced GlaucomaIsrael
-
St. Erik Eye HospitalCompletedOcular Hypertension | Glaucoma | Open Angle Glaucoma | Pseudo Exfoliation SyndromeSweden
-
University of ZurichCompleted
-
Prince of Songkla UniversityCompletedIntraocular Pressure | Corneal EdemaThailand
-
Hillel Yaffe Medical CenterUnknown